UNSPSC 85782423: Insertion of other device into left knee region, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to insertion of other device into left knee region, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0YHG3YZ

UNSPSC 85782423 Insertion of other device into left knee region, percutaneous approach is a Commodity code that bears no substantive relationship to the state and local procurement activity tagged under it. The recent opportunities posted under this code span occupational medical surveillance, disability medical evaluations, pharmacy benefit management, temporary health professional staffing, surgical procedure carve-outs for employee health plans, and emergency medical services for detained youth — none of which involve insertion of devices into the knee or any orthopedic procedure coding. The mismatch suggests either a systematic classification error in the state and local procurement database or incidental tagging unrelated to the code's medical procedure definition. The code shows little relevant recent activity aligned with its stated scope.

The issuing bodies tagged under this code include city pension boards (Phoenix), municipal health systems (Long Beach, Santa Clara County), state transportation departments (Washington State Department of Transportation), county government (Harris County, Collier County), and county health systems, with recent opportunities concentrated in California, Arizona, Washington, and Texas. Representative solicitations include the City of Phoenix Retirement Office's RFP for independent medical evaluation services (due October 16, 2026), the Washington State Department of Transportation's RFP for occupational medical surveillance (due October 9, 2026), and Collier County's RFP for pharmacy benefit management services covering approximately $8.7 million in annual pharmacy spending (due April 9, 2026). None of these opportunities involve orthopedic device insertion or match the Commodity code's clinical definition.